Back to search

Article

TMScal: A Clinical Decision Support Tool for Prognostic Stratification of Microsatellite-Stable Cancers

2026-08-24

Abstract excerpt

PURPOSE Microsatellite-stable (MSS) cancers comprise 70–85% of patients but lack prognostic biomarkers to guide clinical decision-making. Current metrics—tumor mutational burden (TMB), copy number variation (CNV), and microsatellite instability (MSI)—measure the quantity of genomic instability but discard sequence-context information that encodes repair pathway activity. We developed TMScal, a clinical decision su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2135b0a8-fc1c-5890-b201-403c2c29f5b9
DOI
10.20944/preprints202608.1628.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TMScal: A Clinical Decision Support Tool for Prognostic Stratification of Microsatellite-Stable CancersDOI 10.20944/preprints202608.1628.v1
Select a neighboring publication to make it the new centre.